Protara Therapeutics, Inc.
TARABiotechnology
$2.52+1.20%As of Oct 29vs prior close
- Market cap
- $148.9M
- P/E (TTM)
- –
- From 52W high
- −66.67%
- EPS (LTM)
- -$1.37
- Dividend yield
- 0.00%
Nomior Score
31
Steady ProfileBottom 16% of the scored universe
Growth—
Quality46
Value39
Momentum21
Resilience42
Connections
Who owns it
2funds